{"componentChunkName":"component---src-templates-topic-topic-tsx","path":"/topics/influenza-seasonal/","result":{"data":{"firstChapter":{"id":"415ca83c-583b-5dd7-8ce7-a67a72325836","slug":"summary","fullItemName":"Summary","subChapters":[],"depth":1,"htmlHeader":"<!-- begin field 08582b2c-65f5-4135-9cb9-02025ad73185 --><h1>Influenza - seasonal: Summary</h1><!-- end field 08582b2c-65f5-4135-9cb9-02025ad73185 -->","htmlStringContent":"<!-- begin item 29287cd6-4188-4da1-82c4-e50209180047 --><!-- begin field a2e629ca-6af2-4e8a-9e16-b64eaea89925 --><ul><li>Influenza is an acute respiratory illness caused by RNA viruses of the family Orthomyxoviridae (influenza viruses). There are three types of influenza virus:<ul><li>Influenza A occurs more frequently and is more virulent. It is responsible for local outbreaks, larger epidemics and pandemics.</li><li>Influenza B often co-circulates with influenza A during the yearly outbreaks. Generally, influenza B causes less severe clinical illness, although it can still be responsible for outbreaks. </li><li>Influenza C usually causes a mild or asymptomatic infection similar to the common cold.</li></ul></li><li>Influenza usually occurs in the UK during the winter months, typically between December and March. </li><li>Most complications of influenza in adults are respiratory in nature and include:<ul><li>Acute bronchitis.</li><li>Pneumonia.</li><li>Exacerbations of asthma and chronic obstructive pulmonary disease.</li><li>Otitis media.</li><li>Sinusitis.</li></ul></li><li>Influenza presents with symptoms appearing around 2 days after exposure.<ul><li>Uncomplicated influenza signs and symptoms include: coryza, nasal discharge, cough, fever, gastrointestinal symptoms, headache, malaise, myalgia, arthralgia, ocular symptoms, and sore throat. </li><li>Complicated influenza is defined by signs and symptoms that: require hospital admission, involve the lower respiratory tract, central nervous system, or cause significant exacerbation of an underlying medical condition.</li></ul></li><li>For otherwise healthy people, antiviral drugs (oseltamivir or zanamivir) are not usually recommended, unless they are at risk of developing serious complications. If this is the case, oseltamivir should be prescribed if the national surveillance schemes indicate that influenza virus is circulating, and the person can start treatment within 48 hours.</li><li>For people considered to be in an 'at risk' group antiviral drugs should be prescribed if the national surveillance schemes indicate that influenza virus is circulating,<em> </em>and<em> </em>the person can start treatment within 48 hours of the onset of symptoms (36 hours in the case of zanamivir in children). People considered to be in an 'at risk' group include:<ul><li>Those with chronic respiratory, heart, kidney, liver, or neurological disease; diabetes mellitus; or those who are obese or immunosuppressed.</li><li>Those over the age of 65 years.</li><li>Women who are pregnant (or women up to two weeks post partum).</li><li>Children aged under 6 months.</li></ul></li><li>People with influenza should drink adequate fluids, take paracetamol or ibuprofen to relieve symptoms, rest, and stay off work or school until the worst symptoms have resolved (usually about 1 week).</li><li>Post-exposure prophylaxis with an antiviral drug should be started if all of the following apply:<ul><li>The national surveillance scheme indicates that influenza is circulating.</li><li>The person has been in close contact with a person (in the same household or residential setting) who has had recent symptoms of influenza.</li><li>The person is in an 'at risk' group and has not been effectively immunized against influenza.</li><li>The person is able to start treatment within 48 hours of this contact (for oseltamivir) or 36 hours of this contact (for zanamivir).</li></ul></li><li>Urgent admission to hospital should be considered if:<ul><li>A complication such as pneumonia occurs.</li><li>The person has a concomitant disease that may be affected by influenza (for example, type 1 diabetes).</li><li>There is suspicion of a serious illness other than influenza (for example, meningitis).</li></ul></li></ul><!-- end field a2e629ca-6af2-4e8a-9e16-b64eaea89925 --><!-- end item 29287cd6-4188-4da1-82c4-e50209180047 -->","topic":{"id":"7143131b-dc98-5d14-aef2-f50114a27d13","topicId":"c00149e5-18ab-49c6-8576-089384091df2","topicName":"Influenza - seasonal","slug":"influenza-seasonal","aliases":[],"chapters":[{"id":"415ca83c-583b-5dd7-8ce7-a67a72325836","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"39d27467-6801-59da-a28b-29a9a1aa848d","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"7326279e-c8e9-5783-9cb0-433a2e0c5061","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"ecde5124-7df2-5d70-921e-cfa13a752476","slug":"changes","fullItemName":"Changes"},{"id":"b4d67dc6-a391-5644-a3a4-89c1c0c49e3f","slug":"update","fullItemName":"Update"}]},{"id":"3b2a94ae-a366-5ff9-8a35-6f8eb63736a1","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"8b66965c-fc03-5267-ac06-f0edc2bf81ea","slug":"goals","fullItemName":"Goals"},{"id":"32bc1d45-c0ea-55ed-8723-fdbf13b7196e","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"c5aa9558-010a-5b32-b95a-40f647ef373e","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"b9c5c598-f72e-505f-b951-cbe710a6af02","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"d0c6ad8d-5845-5dfd-b2d0-b04bb5395c62","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"48e0bfcd-fd33-552c-b052-28533a176218","slug":"nice-quality-standards","fullItemName":"NICE Quality standards"}]},{"id":"feb6e56c-e4f6-57f4-bbee-0876089197e0","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"bc17d7e2-a53a-595c-9f57-7080c9814001","slug":"definition","fullItemName":"Definition"},{"id":"d0475ee5-11e2-5ad5-8628-4f513e50236f","slug":"prevalence","fullItemName":"Prevalence"},{"id":"a0aabed4-a912-518e-9257-8653bc7541e4","slug":"complications","fullItemName":"Complications"}]},{"id":"f81fdd28-028a-5558-92b2-90a1569692bb","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"dcd79bc4-67e6-52b5-af13-ab18772e4c55","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"4da6c7b5-c872-551a-aff9-100bef3041ca","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"b540d9e5-48f5-5b1c-a8b1-8a37d951449f","slug":"management","fullItemName":"Management","subChapters":[{"id":"9cbc6ee5-b0da-5b46-9ce4-3704f7cf24a9","slug":"treating-influenza","fullItemName":"Scenario: Treating influenza"},{"id":"b82606d4-79c4-5b96-84cd-115c371c80b4","slug":"post-exposure-prophylaxis","fullItemName":"Scenario: Post-exposure prophylaxis"}]},{"id":"267c67be-5fb6-510f-b3f7-15ece61003d9","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"418c695e-c703-5e30-9ec2-9bf2afeb6001","slug":"oseltamivir","fullItemName":"Oseltamivir"},{"id":"370b7394-2bad-5d4f-ac2a-06de67bbefea","slug":"zanamivir","fullItemName":"Zanamivir"}]},{"id":"83f51ef5-d6f9-5101-849d-c72bd5975126","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"fe85159c-da36-5171-9b52-88d8edd9ee77","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"46f280be-d769-501b-905f-789bbf2d8454","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"9904923d-c7de-53aa-8253-15c9392ece2e","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"3790de44-d79a-5486-b053-d09c6dccc2cc","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"7e631b66-3030-5dd0-97e7-7504198b5a14","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"ab624014-37fa-5613-976c-e2ffa65a7e90","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"85b4d3fc-b6de-5df4-ad98-bf9ea439e342","slug":"references","fullItemName":"References","subChapters":[]}]}},"topic":{"id":"7143131b-dc98-5d14-aef2-f50114a27d13","topicId":"c00149e5-18ab-49c6-8576-089384091df2","topicName":"Influenza - seasonal","slug":"influenza-seasonal","aliases":[],"topicSummary":"Influenza is an acute respiratory illness caused by RNA viruses of the family Orthomyxoviridae (influenza viruses).","lastRevised":"Last revised in August 2020","nextPlannedReviewBy":"2023-04-01T00:00:00+01:00","nextPlannedReviewByDateTime":"2023-03","nextPlannedReviewByDisplay":"March 2023","specialities":[{"id":"e174a859-759f-5b1d-898e-1a4155645e13","name":"Infections and infestations","slug":"infections-infestations"},{"id":"164e61aa-02a9-5edf-9943-5d891add3a7f","name":"Respiratory","slug":"respiratory"}],"chapters":[{"id":"415ca83c-583b-5dd7-8ce7-a67a72325836","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"39d27467-6801-59da-a28b-29a9a1aa848d","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"7326279e-c8e9-5783-9cb0-433a2e0c5061","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"ecde5124-7df2-5d70-921e-cfa13a752476","slug":"changes","fullItemName":"Changes"},{"id":"b4d67dc6-a391-5644-a3a4-89c1c0c49e3f","slug":"update","fullItemName":"Update"}]},{"id":"3b2a94ae-a366-5ff9-8a35-6f8eb63736a1","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"8b66965c-fc03-5267-ac06-f0edc2bf81ea","slug":"goals","fullItemName":"Goals"},{"id":"32bc1d45-c0ea-55ed-8723-fdbf13b7196e","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"c5aa9558-010a-5b32-b95a-40f647ef373e","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"b9c5c598-f72e-505f-b951-cbe710a6af02","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"d0c6ad8d-5845-5dfd-b2d0-b04bb5395c62","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"48e0bfcd-fd33-552c-b052-28533a176218","slug":"nice-quality-standards","fullItemName":"NICE Quality standards"}]},{"id":"feb6e56c-e4f6-57f4-bbee-0876089197e0","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"bc17d7e2-a53a-595c-9f57-7080c9814001","slug":"definition","fullItemName":"Definition"},{"id":"d0475ee5-11e2-5ad5-8628-4f513e50236f","slug":"prevalence","fullItemName":"Prevalence"},{"id":"a0aabed4-a912-518e-9257-8653bc7541e4","slug":"complications","fullItemName":"Complications"}]},{"id":"f81fdd28-028a-5558-92b2-90a1569692bb","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"dcd79bc4-67e6-52b5-af13-ab18772e4c55","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"4da6c7b5-c872-551a-aff9-100bef3041ca","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"b540d9e5-48f5-5b1c-a8b1-8a37d951449f","slug":"management","fullItemName":"Management","subChapters":[{"id":"9cbc6ee5-b0da-5b46-9ce4-3704f7cf24a9","slug":"treating-influenza","fullItemName":"Scenario: Treating influenza"},{"id":"b82606d4-79c4-5b96-84cd-115c371c80b4","slug":"post-exposure-prophylaxis","fullItemName":"Scenario: Post-exposure prophylaxis"}]},{"id":"267c67be-5fb6-510f-b3f7-15ece61003d9","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"418c695e-c703-5e30-9ec2-9bf2afeb6001","slug":"oseltamivir","fullItemName":"Oseltamivir"},{"id":"370b7394-2bad-5d4f-ac2a-06de67bbefea","slug":"zanamivir","fullItemName":"Zanamivir"}]},{"id":"83f51ef5-d6f9-5101-849d-c72bd5975126","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"fe85159c-da36-5171-9b52-88d8edd9ee77","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"46f280be-d769-501b-905f-789bbf2d8454","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"9904923d-c7de-53aa-8253-15c9392ece2e","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"3790de44-d79a-5486-b053-d09c6dccc2cc","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"7e631b66-3030-5dd0-97e7-7504198b5a14","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"ab624014-37fa-5613-976c-e2ffa65a7e90","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"85b4d3fc-b6de-5df4-ad98-bf9ea439e342","slug":"references","fullItemName":"References","subChapters":[]}]}},"pageContext":{"id":"7143131b-dc98-5d14-aef2-f50114a27d13"}},"staticQueryHashes":["3666801979"]}